Skip to main content

Articles

Page 14 of 76

  1. Sonic Hedgehog (Shh) signaling cascade is one of the complex signaling pathways that control the accurately organized developmental processes in multicellular organisms. This pathway has fundamental roles in t...

    Authors: Soudeh Ghafouri-Fard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen, Mohammad Taheri and Majid Samsami
    Citation: Cancer Cell International 2022 22:282
  2. MicroRNAs (miRNAs) are small-sized transcripts with about 22 nucleotide length. They have been shown to influence almost every aspect of cellular functions through regulation of expression of target genes. miR...

    Authors: Soudeh Ghafouri-Fard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen, Mohammad Taheri and Majid Samsami
    Citation: Cancer Cell International 2022 22:281
  3. Long non-coding RNA (LncRNA) is a novel and diverse class of regulatory transcripts that are frequently dysregulated in numerous tumor types. LncRNAs are involved in a complicated molecular network, regulating...

    Authors: Muhammad Irfan, Zeeshan Javed, Khushbukhat Khan, Naila Khan, Anca Oana Docea, Daniela Calina, Javad Sharifi-Rad and William C. Cho
    Citation: Cancer Cell International 2022 22:280
  4. Cancer is a major health concern and accounts for one of the main causes of death worldwide. Innovative strategies are needed to aid in the diagnosis and treatment of different types of cancers. Recently, ther...

    Authors: Nouf S. Al-Numair, Abdulrahman Theyab, Faisal Alzahrani, Anwar M. Shams, Ibrahim O. Al-Anazi, Atif Abdulwahab A. Oyouni, Osama M. Al-Amer, Charalampos Mavromatis, Islam M. Saadeldin, Wed A. Abdali and Yousef M. Hawsawi
    Citation: Cancer Cell International 2022 22:279

    The Correction to this article has been published in Cancer Cell International 2023 23:56

  5. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and has an extremely poor prognosis. We aimed to determine the latent relationships between TRIM36 regulation of apoptosis and the...

    Authors: Qing Tong, Mingyu Yi, Panpan Kong, Lin Xu, Wukui Huang, Yue Niu, Xiaojing Gan, Huan Zhan, Rui Tian and Dong Yan
    Citation: Cancer Cell International 2022 22:278
  6. Circular RNAs (circRNAs) represent a class of newly identified transcripts that act as competing endogenous RNAs (ceRNAs) to modulate gene expression by competing for the shared microRNAs (miRNAs) in humans. I...

    Authors: Qian Fei, Yuhe Lin, Mi Zhang, Jinshuai Guo and Yuan Liang
    Citation: Cancer Cell International 2022 22:277
  7. Molecular heterogeneity is one of the most important concerns in colorectal cancer (CRC), which results in a wide range of therapy responses and patient prognosis. We aimed to identify the genes with high hete...

    Authors: Ebrahim Salehitabar, Mohammad Mahdevar, Ali Valipour Motlagh, Farzad Seyed Forootan, Sara Feizbakhshan, Dina Zohrabi and Maryam Peymani
    Citation: Cancer Cell International 2022 22:276
  8. The p21-activated kinase (PAK) family (PAKs) plays a key role in the formation and development of human tumors. However, a systematic analysis of PAKs in human cancers is lacking and the potential role of PAKs...

    Authors: Kunjian Lei, Min Luo, Zewei Tu, Shigang Lv, Junzhe Liu, Chuandong Gong, Minhua Ye, Miaojing Wu, Yilei Sheng, Xiaoyan Long, Jingying Li, Xingen Zhu and Kai Huang
    Citation: Cancer Cell International 2022 22:275
  9. Recent advances in omics technology have prompted extraordinary attempts to define the molecular changes underlying the onset and progression of a variety of complex human diseases, including cancer. Since the...

    Authors: Nasrin Gholami, Amin Haghparast, Iraj Alipourfard and Majid Nazari
    Citation: Cancer Cell International 2022 22:274
  10. ING genes belong to family of tumor suppressor genes with regulatory functions on cell proliferation, apoptosis, and cellular senescence. These include a family of proteins with 5 members (ING1-5), which are down...

    Authors: Mohammad Taheri, Bashdar Mahmud Hussen, Sajad Najafi, Atefe Abak, Soudeh Ghafouri-Fard, Majid Samsami and Aria Baniahmad
    Citation: Cancer Cell International 2022 22:272
  11. Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer and is susceptible to develop gemcitabine (GEM) resistance. Decreased expression of human equilibrative nucleoside transporter 1 (...

    Authors: Yue Xi, Ting Li, Yun Xi, Xinyi Zeng, Ying Miao, Rui Guo, Min Zhang and Biao Li
    Citation: Cancer Cell International 2022 22:271
  12. Long Intergenic Non-Protein Coding RNA 1133 (LINC01133) is a long non-coding RNA (lncRNA) which interacts with miR-106a-3p, miR-576-5p, miR-495-3p, miR-205, miR-199a-5p, miR-4784, miR-30a-5p, miR-199a, miR-30b...

    Authors: Soudeh Ghafouri-Fard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen, Mohammad Taheri and Majid Mokhtari
    Citation: Cancer Cell International 2022 22:270
  13. A pharmacological class known as immune checkpoint inhibitors (ICIs) has been developed as a potential treatment option for various malignancies, including HCC. In HCC, ICIs have demonstrated clinically signif...

    Authors: Faezeh Sharafi, Sadegh Abaei Hasani, Samira Alesaeidi, Mohammad Saeed Kahrizi, Ali Adili, Shadi Ghoreishizadeh, Navid Shomali, Rozita Tamjidifar, Ramin Aslaminabad and Morteza Akbari
    Citation: Cancer Cell International 2022 22:269
  14. Marine seaweeds are important sources of drugs with several pharmacological characteristics. The present study aims to evaluate the antitumor and antitumor immunological potentials of the extracts from the bro...

    Authors: Mostafa M. El-Sheekh, Mohamed Nassef, Eman Bases, Shimaa El Shafay and Rania El-shenody
    Citation: Cancer Cell International 2022 22:267
  15. Esophageal cancer is one of the most common cancers with high mortality rate around the world. Although the treatment strategy of this disease has made great progress, the prognosis of advanced patients is not...

    Authors: Zimin Wang, Sikai Wu, Chengchu Zhu and Jianfei Shen
    Citation: Cancer Cell International 2022 22:266
  16. Interaction between tumor cells and tumor microenvironment (TME) is critical to promote tumor progression and metastasis. As the most abundant immune cells in TME, macrophages can be polarized into M2-like tum...

    Authors: Yang Zheng, Shuguang Ren, Yu Zhang, Sihua Liu, Lingjiao Meng, Fei Liu, Lina Gu, Ning Ai and Meixiang Sang
    Citation: Cancer Cell International 2022 22:264
  17. Intra-tumor heterogeneity (ITH) results from the continuous accumulation of mutations during disease progression, thus impacting patients’ clinical outcome. How the ITH evolves across papillary thyroid carcinoma ...

    Authors: Ornella Affinito, Francesca Maria Orlandella, Neila Luciano, Marco Salvatore, Giuliana Salvatore and Monica Franzese
    Citation: Cancer Cell International 2022 22:263
  18. Glioblastoma belongs to the most aggressive type of cancer with a low survival rate that is characterized by the ability in forming a highly immunosuppressive tumor microenvironment. Intercellular communicatio...

    Authors: Mohsen Karami Fath, Jalil Azami, Alireza Masoudi, Reza Mosaddeghi Heris, Elnaz Rahmani, Fatemeh Alavi, Armina Alagheband Bahrami, Zahra Payandeh, Bahman Khalesi, Masoomeh Dadkhah, Navid Pourzardosht and Vahideh Tarhriz
    Citation: Cancer Cell International 2022 22:262
  19. With the combination therapy of PD-1/PD-L1 antibody and antiangiogenic drugs used widely in clinic, a novel method to estimate the prognosis of patients is needed. We aimed to develop a nomogram to examine pro...

    Authors: Hao Huang, Yao Chen, Xuezi Weng, Sirou Li, Lin Zhang and Peisong Chen
    Citation: Cancer Cell International 2022 22:261
  20. As an intelligent disease, tumors apply several pathways to evade the immune system. It can use alternative routes to bypass intracellular signaling pathways, such as nuclear factor-κB (NF-κB), Wnt, and mitoge...

    Authors: Khadijeh Barzaman, Rana Vafaei, Mitra Samadi, Mohammad Hossein Kazemi, Aysooda Hosseinzadeh, Parnaz Merikhian, Shima Moradi-Kalbolandi, Mohammad Reza Eisavand, Houra Dinvari and Leila Farahmand
    Citation: Cancer Cell International 2022 22:259
  21. Naturally, in somatic cells chromosome ends (telomeres) shorten during each cell division. This process ensures to limit proliferation of somatic cells to avoid malignant proliferation; however, it leads to pr...

    Authors: Mohammad Taheri, Soudeh Ghafouri-Fard, Sajad Najafi, Julia Kallenbach, Elmira Keramatfar, Golnaz Atri Roozbahani, Mehdi Heidari Horestani, Bashdar Mahmud Hussen and Aria Baniahmad
    Citation: Cancer Cell International 2022 22:258
  22. Over the past few years, the cancer-related disease has had a high mortality rate and incidence worldwide, despite clinical advances in cancer treatment. The drugs used for cancer therapy, have high side effec...

    Authors: Parina Asgharian, Abbas Pirpour Tazekand, Kamran Hosseini, Haleh Forouhandeh, Tohid Ghasemnejad, Maryam Ranjbar, Muzaffar Hasan, Manoj Kumar, Sohrab Minaei Beirami, Vahideh Tarhriz, Saiedeh Razi Soofiyani, Latipa Kozhamzharova, Javad Sharifi-Rad, Daniela Calina and William C. Cho
    Citation: Cancer Cell International 2022 22:257
  23. Authors: Zeeshan Javed, Khushbukhat Khan, Jesús Herrera-Bravo, Sajid Naeem, Muhammad Javed Iqbal, Haleema Sadia, Qamar Raza Qadri, Shahid Raza, Asma Irshad, Ali Akbar, Željko Reiner, Ahmed Al-Harrasi, Ahmed Al-Rawahi, Dinara Satmbekova, Monica Butnariu, Iulia Cristina Bagiu…
    Citation: Cancer Cell International 2022 22:256

    The original article was published in Cancer Cell International 2021 21:388

  24. The primary purpose of ADCs is to increase the efficacy of anticancer medications by minimizing systemic drug distribution and targeting specific cells. Antibody conjugates (ADCs) have changed the way cancer i...

    Authors: Hany E. Marei, Carlo Cenciarelli and Anwarul Hasan
    Citation: Cancer Cell International 2022 22:255
  25. PI3K/AKT pathway is an important pathway in the carcinogenesis since it has central impacts in the regulation of metabolic pathways, cell proliferation and survival, gene expression and protein synthesis. This...

    Authors: Soudeh Ghafouri-Fard, Ali Noie Alamdari, Yashar Noee Alamdari, Atefe Abak, Bashdar Mahmud Hussen, Mohammad Taheri and Elena Jamali
    Citation: Cancer Cell International 2022 22:254
  26. In addition to being novel biomarkers for poor cancer prognosis, members of Lymphocyte antigen-6 (Ly6) gene family also play a crucial role in avoiding immune responses to tumors. However, it has not been poss...

    Authors: Francesca Pia Caruso, Mario Rosario D’Andrea, Luigi Coppola, Matteo Landriscina, Valentina Condelli, Luigi Cerulo, Guido Giordano, Almudena Porras and Massimo Pancione
    Citation: Cancer Cell International 2022 22:253
  27. Nectin-4 is specifically up-regulated in various tumors, exert crucial effects on tumor occurrence and development. Nevertheless, the role and molecular mechanism of Nectin-4 in osteosarcoma (OS) are rarely st...

    Authors: Yongheng Liu, Guanghao Li, Yan Zhang, Lili Li, Yanting Zhang, Xiaoyu Huang, Xianfu Wei, Peng Zhou, Ming Liu, Gang zhao, Jinyan Feng and Guowen Wang
    Citation: Cancer Cell International 2022 22:252
  28. The prognosis of non-small cell lung cancer (NSCLC) with brain metastases (BMs) had been researched in some researches, but the combination of clinical characteristics and serum inflammatory indexes as a nonin...

    Authors: Xiaohui Li, Wenshen Gu, Yijun Liu, Xiaoyan Wen, Liru Tian, Shumei Yan and Shulin Chen
    Citation: Cancer Cell International 2022 22:251
  29. Biliary tract cancer (BTC) has a poor prognosis; therefore, useful biomarkers and treatments are needed. Serum levels of macrophage inhibitory cytokine-1 (MIC-1), a member of the TGF-β superfamily, are elevate...

    Authors: Mitsuru Sugimoto, Rei Suzuki, Yoshihiro Nozawa, Tadayuki Takagi, Naoki Konno, Hiroyuki Asama, Yuki Sato, Hiroki Irie, Jun Nakamura, Mika Takasumi, Minami Hashimoto, Tsunetaka Kato, Ryoichiro Kobashi, Osamu Suzuki, Yuko Hashimoto, Takuto Hikichi…
    Citation: Cancer Cell International 2022 22:250
  30. Despite the significant progress in decreasing the occurrence and mortality of hepatocellular carcinoma (HCC), it remains a public health issue worldwide on the basis of its late presentation and tumor recurre...

    Authors: Qikuan He, Pengyi Guo, Zhiyuan Bo, Haitao Yu, Jinhuan Yang, Yi Wang and Gang Chen
    Citation: Cancer Cell International 2022 22:249
  31. A considerable number of glioblastoma (GBM) patients developed drug resistance to Temozolomide (TMZ) during chemotherapy, resulting in therapeutic failure and tumor recurrence. However, the exact mechanism of ...

    Authors: Shuai Yuan, Qi Yan, Zhi-yong Zhao, Jing-long Zhang, He Zhang, Hang Yin and Zhi Yuan
    Citation: Cancer Cell International 2022 22:248
  32. Exercise and physical activity have been shown to be strongly associated with a decreased incidence rate of various chronic diseases especially numerous human malignancies. A huge number of clinical trials and...

    Authors: Ramin Amirsasan, Maryam Akbarzadeh and Shabnam Akbarzadeh
    Citation: Cancer Cell International 2022 22:247
  33. MAPK (mitogen-activated protein kinase) or ERK (extracellular-signal-regulated kinase) pathway is an important link in the transition from extracellular signals to intracellular responses. Because of genetic a...

    Authors: Eunus S. Ali, Shamima Akter, Sarker Ramproshad, Banani Mondal, Thoufiqul Alam Riaz, Muhammad Torequl Islam, Ishaq N. Khan, Anca Oana Docea, Daniela Calina, Javad Sharifi-Rad and William C. Cho
    Citation: Cancer Cell International 2022 22:246
  34. Breast cancer is the most common type of cancer in women and the second leading cause of cancer death in female. Triple-negative breast cancer has a more aggressive proliferation and a poorer clinical diagnosi...

    Authors: Hamid Bakherad, Fahimeh Ghasemi, Maryam Hosseindokht and Hamed Zare
    Citation: Cancer Cell International 2022 22:245
  35. Hepatocellular carcinoma (HCC) is the fifth most common malignant cancer and the third most frequent cause of tumour-related mortality worldwide. Currently, several surgical and medical therapeutic strategies ...

    Authors: Asmaa F. Khafaga, Shaker A. Mousa, Lotfi Aleya and Mohamed M. Abdel-Daim
    Citation: Cancer Cell International 2022 22:243
  36. Nicotinamide adenine dinucleotide (NAD) is the core of cellular energy metabolism. NAMPT, Sirtuins, PARP, CD38, and other molecules in this classic metabolic pathway affect many key cellular functions and are ...

    Authors: QinChen Xu, Xiaoyan Liu, Ghazal Mohseni, Xiaodong Hao, Yidan Ren, Yiwei Xu, Huiru Gao, Qin Wang and Yunshan Wang
    Citation: Cancer Cell International 2022 22:242
  37. NF-E2-related factor 2 (Nrf2) transcription factor has contradictory roles in cancer, which can act as a tumor suppressor or a proto-oncogene in different cell conditions (depending on the cell type and the co...

    Authors: Atefeh Khodakarami, Sara Adibfar, Vahid Karpisheh, Shiva Abolhasani, Pooya Jalali, Hamed Mohammadi, Jamshid Gholizadeh Navashenaq, Mohammad Hojjat-Farsangi and Farhad Jadidi-Niaragh
    Citation: Cancer Cell International 2022 22:241
  38. Long noncoding RNAs (lncRNAs) represent an important group of endogenous RNAs with limit protein-encoding capability, with a length of more than 200 nucleotides. Emerging evidence have demonstrated that lncRNA...

    Authors: Min Su, Jinming Tang, Desong Yang, Zhining Wu, Qianjin Liao, Hui Wang, Yuhang Xiao and Wenxiang Wang
    Citation: Cancer Cell International 2022 22:240
  39. The gaps between the complex nature of cancer and therapeutics have been narrowed down due to extensive research in molecular oncology. Despite gathering massive insight into the mysteries of tumor heterogenei...

    Authors: Zeeshan Javed, Khushbukhat Khan, Jesús Herrera-Bravo, Sajid Naeem, Muhammad Javed Iqbal, Qamar Raza, Haleema Sadia, Shahid Raza, Munir Bhinder, Daniela Calina, Javad Sharifi-Rad and William C. Cho
    Citation: Cancer Cell International 2022 22:239
  40. The B-cell lymphoma 6 (BCL6) oncogene is required for the survival of diffuse large B-cell lymphoma (DLBCL), which is incurable using conventional chemotherapy. Thus, it is imperative to improve the survival of p...

    Authors: Yunying Zhu, Chenshuang Lei, Qian Jiang, Qinhua Yu and Liannv Qiu
    Citation: Cancer Cell International 2022 22:236
  41. Colorectal cancer is the third and most significant cause of death and fourth most common cancer in the world. Chemotherapy can be introduced in the cases of locally or distantly invasive colorectal cancer. In...

    Authors: Arghavan Kouroshnia, Sirous Zeinali, Shiva Irani and Akram Sadeghi
    Citation: Cancer Cell International 2022 22:235
  42. Cancer is one of the major causes of mortality worldwide, therefore it is considered a major health concern. Breast cancer is the most frequent type of cancer which affects women on a global scale. Various cur...

    Authors: Vamika Karn, Sandhya Sandhya, Wayne Hsu, Deepak Parashar, Himanshu Narayan Singh, Niraj Kumar Jha, Saurabh Gupta, Navneet Kumar Dubey and Sanjay Kumar
    Citation: Cancer Cell International 2022 22:234
  43. Glioblastoma is a highly aggressive brain tumor. A big effort is required to find novel molecules which can cross the blood–brain barrier and efficiently kill these tumor cells. In this perspective, trehalose ...

    Authors: Barbara Del Bello, Alessandra Gamberucci, Paola Marcolongo and Emilia Maellaro
    Citation: Cancer Cell International 2022 22:232

Annual Journal Metrics

  • 2022 Citation Impact
    5.8 - 2-year Impact Factor
    5.6 - 5-year Impact Factor
    0.994 - SNIP (Source Normalized Impact per Paper)
    1.145 - SJR (SCImago Journal Rank)

    2023 Speed
    34 days submission to first editorial decision for all manuscripts (Median)
    110 days submission to accept (Median)

    2023 Usage 
    2,067,719 downloads
    1,052 Altmetric mentions 

Institutional membership

Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).

Funding your APC

​​​​​​​Open access funding and policy support by SpringerOpen​​

​​​​We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here